METHOD OF TREATMENT OF NEUROENDOCRINE TUMORS
The present invention relates to methods of treating cancers that over-express somatostatin receptors, e.g. neuroendocrine tumors (NET). In particular, the invention provides novel therapies based on the combination of a peptide receptor radionuclide therapeutic (PRRT) agent and immuno-oncology (I-O...
Saved in:
Main Authors | , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
11.06.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to methods of treating cancers that over-express somatostatin receptors, e.g. neuroendocrine tumors (NET). In particular, the invention provides novel therapies based on the combination of a peptide receptor radionuclide therapeutic (PRRT) agent and immuno-oncology (I-O) therapeutic agents, wherein said I-O therapeutic agents are selected from the group consisting of LAG-3 inhibitors, TIM-3 inhibitors, GITR angonists, TGF-beta inhibitors, IL15/IL-15RA complex, and selected PD-1 inhibitors.
本发明涉及治疗过表达生长抑素受体的癌症、例如神经内分泌肿瘤(NET)的方法。具体而言,本发明提供了基于肽受体放射性核素治疗剂(PRRT)和免疫肿瘤学(I-O)治疗剂的组合的新型疗法,其中所述I-O治疗剂选自由以下组成的组:LAG-3抑制剂、TIM-3抑制剂、GITR激动剂、TGF-β抑制剂、IL15/IL-15RA复合物、和选择的PD-1抑制剂。 |
---|---|
Bibliography: | Application Number: CN201980048954 |